-
Dey, L.P. et al v. Sepracor, Inc. DC CAFC
- 1:07-cv-02353
- S.D.N.Y.
- Judge: John G. Koeltl
+1
- Filed: 03/21/2007
- Closed: 07/02/2013
- Latest Docket Entry: 05/05/2015
- PACER
- Docket updated daily
3
Plaintiffs
1
Defendant
1
Accused
Product
1
Patent-in-Suit
2,296
Days in
Litigation
-
Dey, L.P. et al v. Sepracor, Inc. DC CAFC
- 1:07-cv-02353
- S.D.N.Y.
- Judge: John G. Koeltl
+1
- Filed: 03/21/2007
- Closed: 07/02/2013
- Latest Docket Entry: 05/05/2015
- PACER
- Docket updated daily
Cause of Action
Willful Patent Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 1 |
A pharmaceutical composition, comprising formoterol, or a derivative thereof, in a pharmacologically suitable fluid, wherein the composition is stable during long term storage, the fluid comprises water, and the composition is formulated at a
view more
|
Enforceable and Valid
Entry 231 |
| 2 |
The pharmaceutical composition of claim 1, wherein the composition has an estimated shelf-life of greater than 1 month usage time at 25° C. and greater than or equal to 1 year storage time at 5° C.
|
Enforceable and Valid
Entry 231 |
| 9 |
The pharmaceutical composition of claim 8, wherein the tonicity adjusting agent is sodium chloride.
|
Enforceable and Valid
Entry 231 |
| 32 |
The pharmaceutical composition of claim 31, wherein the buffer concentration is about 5 mM.
|
Enforceable and Valid
Entry 231 |
| 34 |
The pharmaceutical composition of claim 33, wherein the ionic strength of the composition is about 0.05 to about 0.16.
|
Enforceable and Valid
Entry 231 |
| 37 |
The pharmaceutical composition of claim 36, wherein the pH of the composition is about 4.5 to about 5.5.
|
Enforceable and Valid
Entry 231 |
| 40 |
The pharmaceutical composition of claim 39, wherein the formoterol free base concentration is about 10 μg/mL to about 1 mg/mL.
|
Enforceable and Valid
Entry 231 |
| All Claims |
NA
|
Invalid (102)
Entry 167 |
-
Infringement
Sunovion Pharmaceuticals Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| arformoterol tartrate inhalation solutionBROVANA | US 6,667,344 B2 |
1, 2, 9, 32, 34, 37, 40
|
Infringement
Entry 231
|
